Repligen (Germany) Performance
| RGN Stock | EUR 141.40 1.35 0.95% |
On a scale of 0 to 100, Repligen holds a performance score of 7. The company holds a Beta of 0.37, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Repligen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Repligen is expected to be smaller as well. Please check Repligen's potential upside, skewness, and the relationship between the maximum drawdown and semi variance , to make a quick decision on whether Repligen's historical price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Repligen are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Repligen reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 603.8 M | |
| Free Cash Flow | 38.7 M |
Repligen |
Repligen Relative Risk vs. Return Landscape
If you would invest 12,615 in Repligen on October 15, 2025 and sell it today you would earn a total of 1,525 from holding Repligen or generate 12.09% return on investment over 90 days. Repligen is currently producing 0.2193% returns and takes up 2.2883% volatility of returns over 90 trading days. Put another way, 20% of traded stocks are less volatile than Repligen, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Repligen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Repligen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Repligen, and traders can use it to determine the average amount a Repligen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0958
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RGN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.29 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Repligen is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Repligen by adding it to a well-diversified portfolio.
Repligen Fundamentals Growth
Repligen Stock prices reflect investors' perceptions of the future prospects and financial health of Repligen, and Repligen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Repligen Stock performance.
| Return On Equity | 0.1 | |||
| Return On Asset | 0.0509 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.25 % | |||
| Current Valuation | 8.44 B | |||
| Shares Outstanding | 55.56 M | |||
| Price To Earning | 141.37 X | |||
| Price To Book | 5.20 X | |||
| Price To Sales | 11.79 X | |||
| Revenue | 801.54 M | |||
| EBITDA | 271.29 M | |||
| Cash And Equivalents | 196.14 M | |||
| Cash Per Share | 4.15 X | |||
| Total Debt | 124.78 M | |||
| Debt To Equity | 19.90 % | |||
| Book Value Per Share | 34.39 X | |||
| Cash Flow From Operations | 172.08 M | |||
| Earnings Per Share | 2.73 X | |||
| Total Asset | 2.52 B | |||
About Repligen Performance
By analyzing Repligen's fundamental ratios, stakeholders can gain valuable insights into Repligen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Repligen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Repligen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Repligen Corporation develops, manufactures, and sells products used to enhance the interconnected phases of the biological drug manufacturing process in North America, Europe, APAC, and internationally. The company was founded in 1981 and is headquartered in Waltham, Massachusetts. REPLIGEN CORP operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 548 people.Things to note about Repligen performance evaluation
Checking the ongoing alerts about Repligen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Repligen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 98.0% of the company shares are owned by institutional investors |
- Analyzing Repligen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Repligen's stock is overvalued or undervalued compared to its peers.
- Examining Repligen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Repligen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Repligen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Repligen's stock. These opinions can provide insight into Repligen's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Repligen Stock analysis
When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |